Exciva raises EUR9 million in Series A round led by Andera Partners
Exciva, a clinical biotech company developing a novel therapeutic compound for treating agitation/aggression in Alzheimer’s disease, has closed a Series A financing of EUR9 million (USD10 million) led by Andera Partners. LBBW Venture Capital and Cure8 also participated in the round. This first funding will help Exciva GmbH develop the